Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.68 |
| ▸ | MEN1 | O00255 | 3/20 | 0.68 |
| ▸ | HPGD | P15428 | 3/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.68 |
| ▸ | MAPT | P10636 | 4/20 | 0.67 |
| ▸ | UBE2T | Q9NPD8 | 1/20 | 0.61 |
| ▸ | ASIC3 | Q9UHC3 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | GAA | P10253 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 4/20 | 0.56 |
| ▸ | NPC1 | O15118 | 4/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | CASP1 | P29466 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3684279 | 0.84 | MAPT (0.60) | KMT2AMEN1HPGDALDH1A1MAPT | |
| SCHEMBL1612659 | 0.84 | SMN1; SMN2 (0.67) | KMT2AMEN1HPGDALDH1A1MAPT | |
| SCHEMBL5212645 | 0.83 | HPGD (0.68) | KMT2AMEN1HPGDALDH1A1MAPT | |
| SCHEMBL5312416 | 0.83 | MAPT (0.58) | KMT2AMEN1HPGDALDH1A1MAPT | |
| Bromide SCHEMBL3868424 | 0.83 | SMN1; SMN2 (0.65) | KMT2AMEN1HPGDALDH1A1MAPT | |
| SCHEMBL1398257 | 0.83 | MAPT (0.67) | KMT2AMEN1HPGDALDH1A1MAPT | |
| SCHEMBL1248387 | 0.83 | MAPT (0.58) | KMT2AMEN1HPGDALDH1A1MAPT | |
| SCHEMBL11266911 | 0.83 | MAPT (0.67) | KMT2AMEN1HPGDALDH1A1MAPT | |
| SCHEMBL7656563 | 0.83 | MAPT (0.58) | KMT2AMEN1HPGDALDH1A1MAPT | |
| SCHEMBL5401256 | 0.83 | MAPT (0.67) | KMT2AMEN1HPGDALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 266 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2753604-B1 | PDE10 MODULATORS | HOFFMANN LA ROCHE (CH) | 2015-08-19 | — | — | EP | claimed |
| US-8772510-B2 | PDE10 modulators | HOFFMANN-LA ROCHE INC. (US) | 2014-07-08 | — | — | US | claimed |
| EP-2574607-A1 | PDE10 modulators | F. Hoffmann-La Roche AG (CH) | 2013-04-03 | — | — | EP | claimed |
| WO-2013034506-A1 | PDE10 MODULATORS | F. HOFFMANN-LA ROCHE AG (CH) | 2013-03-14 | — | — | WO | claimed |
| US-20130059833-A1 | PDE10 MODULATORS | F. HOFFMANN-LA ROCHE AG (CH) | 2013-03-07 | — | — | US | claimed |
| EP-2393790-A1 | DERIVATIVES OF 6-(6-O-CYCLOALKYL OR 6-NH-CYCLOALKYL-TRIAZOLOPYRIDAZINE-SULFANYL) BENZOTHIAZOLES AND BENZIMIDAZOLES, PREPARATION THEREOF, USE THEREOF AS DRUGS, AND USE THEREOF AS MET INHIBITORS | SANOFI (FR) | 2011-12-14 | — | — | EP | claimed |
| WO-2010089506-A1 | DERIVATIVES OF 6-(6-O-CYCLOALKYL OR 6-NH-CYCLOALKYL-TRIAZOLOPYRIDAZINE-SULFANYL) BENZOTHIAZOLES AND BENZIMIDAZOLES, PREPARATION THEREOF, USE THEREOF AS DRUGS, AND USE THEREOF AS MET INHIBITORS | SANOFI-AVENTIS (FR) | 2010-08-12 | — | — | WO | claimed |
| EP-2183232-A2 | PI3 KINASE MODULATORS AND METHODS OF USE | Amgen, Inc (US) | 2010-05-12 | — | — | EP | claimed |
| CN-100520574-C | Silver halide photosensitive material | FUJI PHOTO FILM CO LTD (JP) | 2009-07-29 | — | — | CN | claimed |
| WO-2009081222-A1 | SUBSTITUTED TRICYCLIC PYRIDINE OR PYRIMIDINE VANILLOID RECEPTOR LIGANDS | GLENMARK PHARMACEUTICALS, S.A. (US) | 2009-07-02 | — | — | WO | claimed |
| US-4698297-A | INCLUDING A CHEMICALLY STABLE COMPOUND ABLE TO RELEASE A USEFUL CONTROLLABLE GROUP HAVING GOOD DIFFUSION; SHARPNESS | FUJI PHOTO FILM CO., LTD. (JP) | 1987-10-06 | — | — | US | claimed |
| EP-0208502-A2 | Light-sensitive silver halide color photographic material | KONICA CORPORATION (JP) | 1987-01-14 | — | — | EP | claimed |
| US-4618571-A | STORAGE-STABLE COUPLERS; CONTROLLED-RELEASABLE COMPOUNDS | FUJI PHOTO FILM CO., LTD. (JP) | 1986-10-21 | — | — | US | claimed |
| US-4565777-A | Silver halide color photographic light-sensitive materials | FUJI PHOTO FILM CO., LTD. (JP) | 1986-01-21 | — | — | US | claimed |
| EP-0157146-A2 | Silver halide color photographic light-sensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 1985-10-09 | — | — | EP | claimed |
| US-4533625-A | COLOR COUPLER COMPRISING HYDROXYNAPHTHYL-SULFONYL OR -SULFINYL COMPOUND | FUJI PHOTO FILM CO., LTD. (JP) | 1985-08-06 | — | — | US | claimed |
| US-4526861-A | Heterocyclic ring contains imide or sulfonamide group | FUJI PHOTO FILM CO., LTD. (JP) | 1985-07-02 | — | — | US | claimed |
| US-4511649-A | Silver halide color photographic light-sensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 1985-04-16 | — | — | US | claimed |
| EP-0126433-A2 | Silver halide color photographic light-sensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 1984-11-28 | — | — | EP | claimed |
| US-4477563-A | DEVELOPMENT INHIBITION RELEASING COUPLERS | FUJI PHOTO FILM CO., LTD. (JP) | 1984-10-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130059833-A1 | PDE10 MODULATORS | PDE10A, PDE5A, PDE2A | KMT2A 2193/4885MEN1 2291/4885HPGD 1466/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.